Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof

Details for Australian Patent Application No. 2004314347 (hide)

Owner Aduro BioTech

Inventors Dubensky, Thomas W. Jr.; Luckett, William S. Jr.; Portnoy, Daniel A.; Cook, David N.

Agent FB Rice

Pub. Number AU-B-2004314347

PCT Pub. Number WO2005/071088

Priority 60/599,377 05.08.04 US; 10/773,618 06.02.04 US; 60/541,515 02.02.04 US; 60/556,744 26.03.04 US; 60/615,287 01.10.04 US; 60/532,598 24.12.03 US; 10/883,599 30.06.04 US; 60/616,750 06.10.04 US; PCT/ US2004/023881 23.07.04 US; 10/773,792 06.02.04 US

Filing date 23 December 2004

Wipo publication date 4 August 2005

Acceptance publication date 19 May 2011

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/071088 Priority application(s): WO2005/071088

10 July 2008 Assignment before Grant

  Cerus Corporation The application has been assigned to Anza Therapeutics, Inc. 2005

4 February 2010 Assignment before Grant

  Anza Therapeutics, Inc. The application has been assigned to Aduro BioTech 2005

19 May 2011 Application Accepted

  Published as AU-B-2004314347

15 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004314348-Tamper evident closures

2004314343-Electrochemical nitrate destruction